Replies to post #13159 on Sorrento Therapeutics Inc (SRNE)

[1776club]

Does this answer what the 10K will be.
"(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year
will be reflected by the earnings statements to be included in the
subject report or portion thereof? ? Yes ? No"
The only change I expect is a -$340 million loss.
Nor sure what to expect from COVISRIX as it looks like nothing developed in San Diego with respect to manufacturing. With respect to Fortune Bio "Sorrento’s exclusive OEM manufacturer for COVISTIX."
Maybe 1 million pcs sold 2021???????